论文信息 - Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses. - 字舞流文

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses.

Jie Yang | M. Ahn | T. Mok | Yi-long Wu | Jin-Ji Yang | J. Soria | V. Haddad | K. Thress | Xiaojin Shi | K. Nakagawa | Jie Wang | Y. Rukazenkov | S. Atagi | You Lu | S. Ponce | Sang-We Kim | Jin-Ji Yang | James Chih-Hsin Yang